PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
293.08%
Some net income increase while VET is negative at -1661.28%. John Neff would see a short-term edge over the struggling competitor.
No Data
No Data available this quarter, please select a different quarter.
185.71%
Some yoy growth while VET is negative at -132.89%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Slight usage while VET is negative at -428.84%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
100.00%
AR growth of 100.00% while VET is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Some yoy usage while VET is negative at -428.84%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-100.00%
Negative yoy while VET is 36.40%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-100.00%
Both yoy CFO lines are negative, with VET at -49.90%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
15.56%
Lower CapEx growth vs. VET's 36.59%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
100.00%
Acquisition spending well above VET's 99.85%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-125.00%
Both yoy lines negative, with VET at -856.39%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
37.65%
Lower net investing outflow yoy vs. VET's 84.15%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-100.00%
Both yoy lines negative, with VET at -85.57%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.